"Sure, the upfront costs of doing a spinal cord stimulator are going to
be high," says Dr. Christo, "but over time, the break-even point might
only be 2
1
⁄2 years."
Worthwhile endeavor
Your facility can take advantage of the paradigm shift in how we treat
chronic pain. Dr. Christo says the investment in procedural interven-
tions for pain control is worth it for 2 reasons.
"These can make a big difference in someone's life. They can drasti-
cally improve the function of patients with chronic pain, so there's the
public health aspect," he says. "Plus, most of these things are reim-
bursable."
With the push to reduce or eliminate opioid use among chronic pain
patients getting stronger each day, you can imagine the reimbursement
will only become more favorable moving forward.
OSM
9 2 • O U T PA T I E N T S U R G E R Y M A G A Z I N E • D E C E M B E R 2 0 1 9